Inventor
YIN ZHIWEI
US45 patents
⚠️ This page may combine multiple inventors who share the name “YIN ZHIWEI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
26 patentsUS7354924B2Apr 8, 2008
Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
BRISTOL MYERS SQUIBB CO106 citations99
US7807676B2Oct 5, 2010
Diketo-Piperazine and Piperidine derivatives as antiviral agents
BRISTOL MYERS SQUIBB CO17 citations92
US7807671B2Oct 5, 2010
Diketo-piperazine and piperidine derivatives as antiviral agents
BRISTOL MYERS SQUIBB CO29 citations92
US7662823B2Feb 16, 2010
Pharmaceutical formulations of substituted azaindoleoxoacetic piperazine derivatives
BRISTOL MYERS SQUIBB CO17 citations92
US7501420B2Mar 10, 2009
Composition and antiviral of substituted azaindoleoxoacetic piperazine derivatives
BRISTOL MYERS SQUIBB CO21 citations92
US7348337B2Mar 25, 2008
Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides
BRISTOL MYERS SQUIBB CO37 citations92
US7396830B2Jul 8, 2008
Piperazine amidines as antiviral agents
BRISTOL MYERS SQUIBB CO16 citations84
US7960406B2Jun 14, 2011
Diketo substituted pyrrolo[2,3-c] pyridines
BRISTOL MYERS SQUIBB CO5 citations74
US10131645B2Nov 20, 2018
Benzofurans substituted with primary benzamide as HCV inhibitors
BRISTOL MYERS SQUIBB CO2 citations73
US10125111B2Nov 13, 2018
Benzofuran compounds for the treatment of hepatitis C
BRISTOL MYERS SQUIBB CO3 citations73
US8916702B2Dec 23, 2014
Compounds for the treatment of hepatitis C
BRISTOL MYERS SQUIBB CO4 citations73
US9156828B2Oct 13, 2015
Tricyclic amidine derivatives as HIV attachment inhibitors
BRISTOL MYERS SQUIBB CO3 citations63
US8987264B2Mar 24, 2015
1,3,5-triazine derivatives of spiro bicyclic oxalamide-compounds for treatment of hepatitis C
BRISTOL MYERS SQUIBB CO2 citations63
US7915283B2Mar 29, 2011
Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides
BRISTOL MYERS SQUIBB CO3 citations61
US6774134B2Aug 10, 2004
Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
BRISTOL MYERS SQUIBB CO5 citations61
US10570108B2Feb 25, 2020
Substituted benzofuran compounds for the treatment of hepatitis C
BRISTOL MYERS SQUIBB CO0 citations52
US10125137B2Nov 13, 2018
Benzofurans substituted with bicyclic secondary benzamide as HCV inhibitors
BRISTOL MYERS SQUIBB CO0 citations52
US9918988B2Mar 20, 2018
Ammonium derivatives for the treatment of hepatitis C
BRISTOL MYERS SQUIBB CO0 citations52
US9920036B2Mar 20, 2018
Cyanoamino (aza)benzofuran compounds for the treatment of hepatitis C
BRISTOL MYERS SQUIBB CO1 citations52
US9745322B2Aug 29, 2017
Compounds for the treatment of hepatitis C
BRISTOL MYERS SQUIBB CO0 citations52
US6844342B2Jan 18, 2005
Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
BRISTOL MYERS SQUIBB CO0 citations50
US10087167B2Oct 2, 2018
Benzofurans substituted with secondary benzamide as HCV inhibitors
BRISTOL MYERS SQUIBB CO0 citations42
US9655902B2May 23, 2017
Guanidine derivatives for the treatment of hepatitis C
BRISTOL MYERS SQUIBB CO0 citations42
US9624245B2Apr 18, 2017
Macrocyclic compounds as HCV entry inhibitors
BRISTOL MYERS SQUIBB CO0 citations42
US9249152B2Feb 2, 2016
Cyano containing azabenzofuran compounds for the treatment of hepatitis C
BRISTOL MYERS SQUIBB CO0 citations42
US8987265B2Mar 24, 2015
Substituted 1,3,5-triazine derivatives of fused bicyclic oxalamide compounds for treatment of Hepatitis C
BRISTOL MYERS SQUIBB CO0 citations42
WANG TAO
4 patentsUS8741884B2Jun 3, 2014
Compounds for the treatment of hepatitis C
WANG TAO4 citations73
US8450361B2May 28, 2013
Substituted indole and azaindole oxoacetyl piperazinamide derivatives
WANG TAO5 citations73
US8912195B2Dec 16, 2014
Alkyl amides as HIV attachment inhibitors
WANG TAO3 citations63
US8124615B2Feb 28, 2012
Diketo substituted pyrrolo[2,3-C]pyridines
WANG TAO3 citations61
VIIV HEALTHCARE UK NO 5 LTD
4 patentsUS10407410B2Sep 10, 2019
Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
VIIV HEALTHCARE UK NO 5 LTD1 citations62
US10214516B2Feb 26, 2019
5-(N-fused tricyclic aryl tetrahydroisoquinolin-6-yl) pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
VIIV HEALTHCARE UK NO 5 LTD1 citations62
US10189816B2Jan 29, 2019
Substituted pyridines as inhibitors of human immunodeficiency virus replication
VIIV HEALTHCARE UK NO 5 LTD1 citations62
US10577353B2Mar 3, 2020
5-(n-[6,5]-fused bicyclic aryl tetrahydroisoquinolin-6-yl) pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
VIIV HEALTHCARE UK NO 5 LTD0 citations52
VIIV HEALTHCARE UK (NO 5) LTD
3 patentsUS9834566B2Dec 5, 2017
Pyrazolopyrimidine macrocycles as inhibitors of human immunodeficiency virus replication
VIIV HEALTHCARE UK (NO 5) LTD1 citations52
US9655888B2May 23, 2017
Tricyclic alkene derivatives as HIV attachment inhibitors
VIIV HEALTHCARE UK (NO 5) LTD0 citations52
US9586957B2Mar 7, 2017
2-keto amide derivatives as HIV attachment inhibitors
VIIV HEALTHCARE UK (NO 5) LTD0 citations52